MAIA

MAIA Biotechnology, Inc. · AMEX

Sector Health Technology
Industry Biotechnology
Website MAIABiotech.com
Employees(FY) 18
ISIN US5526411021

Performance

-14.89%

-13.57%

-24.41%

-32.63%

+90.6%

YTD

+89.79%

Profile

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Advanced Technical Analysis

Technical Analysis of MAIA 2024-11-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 46 suggesting a neutral stance, and a Technical Score of 28 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MAIA

Stock Rank

Recent News & Updates

2024-11-06 19:47
MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement(Yahoo Finance)
2024-11-04 20:45
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting(Yahoo Finance)
2024-10-28 07:00
MAIA Biotechnology Announces $2.44 Million Private Placement(Yahoo Finance)
2024-10-14 20:15
MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics(Yahoo Finance)
2024-09-09 18:00
MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer(Yahoo Finance)
2024-09-03 20:30
MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference(Yahoo Finance)
2024-07-22 16:11
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent(Yahoo Finance)
2024-06-07 00:31
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDAs Approval of a Telomerase Inhibitor Agent Therapy(Yahoo Finance)
2024-06-05 22:07
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent(Yahoo Finance)
2024-06-03 20:41
MAIA Biotechnology Reveals New Clinical Data Showing THIOs Strong Efficacy in Non-Small Cell Lung Cancer(Yahoo Finance)
2024-05-16 20:37
MAIA Biotechnology to Present at the BIO International Convention 2024(Yahoo Finance)
2024-05-15 20:37
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting(Yahoo Finance)
2024-04-29 20:08
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement(Yahoo Finance)
2024-04-28 20:08
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement(Yahoo Finance)
2024-04-22 20:51
MAIA Biotechnology Announces $1.00 Million Private Placement(Yahoo Finance)
2024-04-04 20:01
MAIA Biotechnology to Present at Two Investor Conferences in April 2024(Yahoo Finance)
2024-03-28 03:00
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero(Yahoo Finance)
2024-03-26 03:00
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement(Yahoo Finance)
2024-03-25 20:01
MAIA Biotechnology Announces $1.33 Million Private Placement(Yahoo Finance)
2024-03-22 03:00
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement(Yahoo Finance)
2024-03-21 03:00
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board(Yahoo Finance)
2024-03-15 13:49
Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)(Yahoo Finance)
2024-03-06 20:45
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference(Yahoo Finance)
2024-03-05 22:04
MAIA Biotechnology and Nationwide Childrens Hospital Announce Presentation of THIOs Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting(Yahoo Finance)
2024-03-05 19:48
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients(Yahoo Finance)
2024-03-04 19:45
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders(Yahoo Finance)
2024-02-26 21:30
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor(Yahoo Finance)
2024-02-21 21:30
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer(Yahoo Finance)
2024-02-06 19:01
MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer(Yahoo Finance)
2024-01-23 18:15
MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.